Hints and tips:
Related Special Reports
...They may also explore questions such as how the drugs can push people in the direction of eating healthier food....
...The first mental health treatment using schedule-1 drug MDMA faces a significant regulatory hurdle as the US Food and Drug Administration is poised to ask outside experts to scrutinise it for post-traumatic...
...The drug is marketed by Sanofi as Lyxumia in the EU and Adlyxin in the US, where it was discontinued last year because of low demand....
...A decision from the US Food and Drug Administration on Eli Lilly’s donanemab drug was originally due by the end of the first quarter but the breakthrough medicine will now be subject to a further review...
...Leqembi, priced at $26,500 a year, was the first drug with a black-box warning — the most severe designation about possible side effects — to be granted full approval by the US Food and Drug Administration...
...Sanofi has marketed new prescription drugs recently — including haemophilia treatment Altuviiio, and Beyfortus for respiratory syncytial virus in young children — as it works to improve its drug pipeline...
...These will be the first results from a study designed around landmark US Food and Drug Administration guidelines for researching psychedelics that were outlined last year, a decision that encouraged investors...
...But on Tuesday night, the company announced it had failed to reduce relapse rates for MS patients compared with teriflunomide, which is produced by rival Sanofi....
...The company needs to launch new products to replace its blockbuster asthma and eczema drug Dupixent, where Sanofi’s exclusive rights run out in the early 2030s....
...He now needs to draw heavily on those skills to convince investors that Sanofi has what it takes to develop a new breed of blockbuster drugs solo....
...Sanofi’s operating income fell 5.2 per cent at the end of last year as adverse currency rates and generic competition with multiple sclerosis pill Aubagio hit sales....
...A decision on Eli Lilly’s donanemab drug from the US Food and Drug Administration was originally due by the end of the first quarter, but the medicine will now be subject to a further review by an advisory...
...improvements that we think are going to unlock a lot of new science,” said John Jumper, DeepMind’s AlphaFold team leader, who cited the potential of the technique to improve knowledge of plant biology and thus food...
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...According to a Food and Drug Administration database tracking drug shortages, lower doses of Wegovy have limited availability at present but higher doses and Ozempic injections are in good supply....
...suns in a manner similar to the way . . . the planets revolve around our Sun....
...Eli Lilly said that it plans to submit the results to the US Food and Drug Administration and other medicine regulators worldwide to seek approval for tirzepatide as a sleep apnoea treatment beginning this...
...The US Food and Drug Administration will allow Florida to import medicines from Canada, making it the first state to capitalise on rules designed to lower the cost of prescription drugs....
...The US Food and Drug Administration has approved the first Alzheimer’s drug that can slow the progression of the neurodegenerative disease, paving the way for millions of American patients to access the...
...The US Food and Drug Administration and the UK’s Medicines and Healthcare products Regulatory Agency said patients in clinical trials of Lilly’s tirzepatide had seen “significant” weight loss compared with...
...The US Food and Drug Administration last year approved over-the-counter sales of Narcan — the branded version of naloxone, a nasal spray used to reverse opioid overdoses — in the hope that greater access...
...Ketamine has been approved by the US Food and Drug Administration for use as an anaesthetic since the 1970s. But more recently, specialist clinics have begun touting it as a mental health treatment....
...Sanofi raised its full year earnings guidance after sales of its immunology drug Dupixent soared by more than a third in the second quarter....
...Novo Nordisk’s Wegovy medication, which this month received US Food and Drug Administration approval to help reduce heart attack and stroke risk in patients with a history of cardiovascular problems, can...
...Shares in Sanofi fell 19 per cent on Friday after the French pharmaceutical group announced a lower profit outlook and a spinout of its consumer care unit as it seeks to focus on drug research....
International Edition